Hot

Endocyte, Inc. (NASDAQ: ECYT) today announced that it has entered into an agreement and plan of merger with Novartis AG (NYSE: NVS) pursuant to which Novartis will acquire Endocyte for $24 per share, or a total equity value of approximately $2.1 billion, in cash. This offer represents a premium of...